We provide market intelligence focused on earnings data and stock price behavior.
As of 2026-04-13, Telomir Pharmaceuticals Inc. (TELO) is trading at $1.25, representing a 2.46% gain on the session. This small-cap clinical-stage biotech firm has seen tight trading ranges in recent weeks, with no recently released earnings data available as of this analysis, leading market participants to focus heavily on technical price levels and broader sector trends to gauge near-term price action. TELO’s current price falls squarely between its recently identified near-term support and re
Is Telomir Pharmaceuticals (TELO) Stock Lagging the Market | Price at $1.25, Up 2.46% - Butterfly Setup
TELO - Stock Analysis
4127 Comments
1351 Likes
1
Trajan
Power User
2 hours ago
{协议答案}
👍 157
Reply
2
Hendel
Experienced Member
5 hours ago
{协议答案}
3
Dustyn
Expert Member
1 day ago
{协议答案}
👍 68
Reply
4
Nyjour
Trusted Reader
1 day ago
{协议答案}
👍 164
Reply
5
Jeo
Active Contributor
2 days ago
{协议答案}
👍 202
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.